Synaptic vesicle glycoprotein 2 enables viable aneuploidy following centrosome amplification
GENETICS · 2025
DOI: 10.1093/genetics/iyaf148 ↗Kurz gefasst
Fachartikel in der Zeitschrift GENETICS, 2025. Verfasst von Jane E Blackmer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Duke University, DUMC Box 3813, Durham, NC 27710, United States. Hauptthemen laut MEDLINE: Centrosome, Aneuploidy, Drosophila Proteins, Nerve Tissue Proteins. Die Arbeit nennt 105 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NASA Translational Institute for Space Health (TRISH), NIH HHS.
Abstract (Originalsprache)
Amplified centrosome number causes genomic instability, most severely through division into >2 aneuploid daughter cells (multipolar mitosis). Several mechanisms that suppress multipolar division have been uncovered, yet mechanisms that favor viable multipolar division are poorly understood. To uncover factors that promote viability in cells with frequent centrosome amplification and multipolar division, we conducted an unbiased Drosophila genetic screen. In 642 mutagenized lines, we exploited the ability of intestinal papillar cells to form and function despite multipolar divisions. Our top hit is an unnamed gene, CG3168. We name this gene synaptic vesicle glycoprotein 2, reflecting homology to human Synaptic Vesicle Glycoprotein 2 (SV2) proteins. GFP-tagged SV2 localizes to the plasma membrane. In cells with amplified centrosomes, SV2 positions membrane-adjacent centrosomes, which prevents severe errors in chromosome alignment and segregation. Our results uncover membrane-based multipolar division regulation and reveal a novel vulnerability in cells with common cancer properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Duke University, DUMC Box 3813, Durham, NC 27710, United States.
ORCID-Profile: Jane E Blackmer, Archan Chakraborty, Satya N Yalamanchi, Donald T Fox
Förderung
- NIGMS NIH HHS
- NASA Translational Institute for Space Health (TRISH)
- NIH HHS
- NIH
Zitieren
APA
Blackmer, J. E., Jezuit, E. A., Chakraborty, A., Yalamanchi, S. N., Montague, R. A., Dickert, E. E., Peterson, N. G., Outlaw, W., & Fox, D. T. (2025). Synaptic vesicle glycoprotein 2 enables viable aneuploidy following centrosome amplification. GENETICS. https://doi.org/10.1093/genetics/iyaf148
Vancouver
Blackmer JE, Jezuit EA, Chakraborty A, Yalamanchi SN, Montague RA, Dickert EE, et al. Synaptic vesicle glycoprotein 2 enables viable aneuploidy following centrosome amplification. GENETICS. 2025. doi:10.1093/genetics/iyaf148
BibTeX
@article{Blackmer2025,
author = {Blackmer, Jane E and Jezuit, Erin A and Chakraborty, Archan and Yalamanchi, Satya N and Montague, Ruth A and Dickert, Erin E and Peterson, Nora G and Outlaw, William and Fox, Donald T},
title = {Synaptic vesicle glycoprotein 2 enables viable aneuploidy following centrosome amplification},
journal = {GENETICS},
year = {2025},
doi = {10.1093/genetics/iyaf148}
}
EUVIMED